As of 2025-12-26, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (15.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -167.2%.
The range of the Relative Valuation is (11.00) - (21.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 14.8x | 10.0x |
| Forward P/E multiples | 7.7x - 15.6x | 11.6x |
| Fair Price | (11.00) - (21.12) | (15.46) |
| Upside | -147.8% - -191.8% | -167.2% |
| Date | P/E |